1643 Stock Overview
An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Modern Chinese Medicine Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.36 |
| 52 Week High | HK$0.44 |
| 52 Week Low | HK$0.28 |
| Beta | 0.38 |
| 11 Month Change | 15.87% |
| 3 Month Change | 4.29% |
| 1 Year Change | -10.98% |
| 33 Year Change | -47.86% |
| 5 Year Change | n/a |
| Change since IPO | -71.03% |
Recent News & Updates
Modern Chinese Medicine Group's (HKG:1643) Conservative Accounting Might Explain Soft Earnings
Sep 30
Modern Chinese Medicine Group Co., Ltd. (HKG:1643) Stock Catapults 25% Though Its Price And Business Still Lag The Market
May 22Recent updates
Modern Chinese Medicine Group's (HKG:1643) Conservative Accounting Might Explain Soft Earnings
Sep 30Modern Chinese Medicine Group Co., Ltd. (HKG:1643) Stock Catapults 25% Though Its Price And Business Still Lag The Market
May 22Lacklustre Performance Is Driving Modern Chinese Medicine Group Co., Ltd.'s (HKG:1643) Low P/E
Mar 25We Think You Should Be Aware Of Some Concerning Factors In Modern Chinese Medicine Group's (HKG:1643) Earnings
Sep 02Calculating The Fair Value Of Modern Chinese Medicine Group Co., Ltd. (HKG:1643)
Jun 07Shareholder Returns
| 1643 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | -3.9% | -3.7% | -6.2% |
| 1Y | -11.0% | 24.4% | 17.6% |
Return vs Industry: 1643 underperformed the Hong Kong Pharmaceuticals industry which returned 24.4% over the past year.
Return vs Market: 1643 underperformed the Hong Kong Market which returned 17.6% over the past year.
Price Volatility
| 1643 volatility | |
|---|---|
| 1643 Average Weekly Movement | 5.9% |
| Pharmaceuticals Industry Average Movement | 6.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in HK Market | 18.5% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 1643 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 1643's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 190 | Hongli Zhang | www.cdysjdyy.com |
Modern Chinese Medicine Group Co., Ltd., an investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China. The company offers vigour and vitality supplement, circulation enhancement, kidney invigoration, menstrual discomfort relief, huoxiang zheng qi, liver-dispersing and stomach regulating, and fever- removing and detoxification pills; cardiotonic enhancement and heart wellness capsules; and liver detox tablets. It offers its products as therapeutics for the qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, and respiratory system conditions.
Modern Chinese Medicine Group Co., Ltd. Fundamentals Summary
| 1643 fundamental statistics | |
|---|---|
| Market cap | HK$219.00m |
| Earnings (TTM) | HK$15.75m |
| Revenue (TTM) | HK$263.82m |
13.9x
P/E Ratio0.8x
P/S RatioIs 1643 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1643 income statement (TTM) | |
|---|---|
| Revenue | CN¥240.61m |
| Cost of Revenue | CN¥173.96m |
| Gross Profit | CN¥66.65m |
| Other Expenses | CN¥52.29m |
| Earnings | CN¥14.36m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.024 |
| Gross Margin | 27.70% |
| Net Profit Margin | 5.97% |
| Debt/Equity Ratio | 0.1% |
How did 1643 perform over the long term?
See historical performance and comparison